Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01401907 · ClinicalTrials.gov registry record · NA

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
351
Enrollment target

NCT01401907: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01401907 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 351 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01401907, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
351 participants
Enrollment target

Study Summary

The purpose of this study is to compare two types of care - standard oncology care and standard oncology care with early palliative care (started soon after diagnosis) to see which is better for improving the experience of patients and families with advanced lung and non-colorectal GI cancer. The study will use questionnaires to measure patients' and caregivers' quality of life, mood, coping and understanding of their illness.

Interventions

  • OTHER early palliative care

Trial Details

FieldValue
Enrollment Target 351 participants
Start Date 2011-05
Est. Completion 2019-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01401907

The ClinicalTrials.gov registry entry for NCT01401907 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 351 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which early palliative care is the first listed.

NCT01401907 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01401907 about?

NCT01401907 is a clinical study titled "Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies". The purpose of this study is to compare two types of care - standard oncology care and standard oncology care with early palliative care (started soon after diagnosis) to see which is better for improving the experience of patients and families with advanced lung and non-colorectal GI cancer. The st...

What is the current status of trial NCT01401907?

This trial is currently completed. It is a NA study. The enrollment target is 351 participants. The study started on 2011-05. Estimated completion is 2019-12.

What interventions are being tested in trial NCT01401907?

The interventions under investigation include: early palliative care (OTHER).

Who is sponsoring clinical trial NCT01401907?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.